IBS Primary Logo Blue.png
Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology
December 18, 2024 08:30 ET | Intelligent Bio Solutions, Inc.
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
logo-dark.png
Rezolve Ai Announces $49 Million Equity Conversion by Leading Investors
December 18, 2024 08:30 ET | Rezolve AI Ltd
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-driven retail innovation, and its leading investors have entered into a series of transactions agreeing...
Logo file.jpg
New Century Logistics Prices $6 Million Initial Public Offering
December 18, 2024 08:30 ET | New Century Logistics
HONG KONG, Dec. 18, 2024 (GLOBE NEWSWIRE) -- New Century Logistics (BVI) Limited (“New Century” or the “Company”), an international freight forwarding company and logistics service provider,...
Carma HoldCo Logo.png
Evol by Future to Launch in Ohio Cannabis Market in Partnership with Dompen
December 18, 2024 08:30 ET | Carma HoldCo Inc.
LAS VEGAS, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Carma HoldCo Inc, a leading global house of brands known for harnessing the power of cultural icons to transform industries, announced the launch of Evol...
Coherus_Logo_RGB_150.png
Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
December 18, 2024 08:30 ET | Coherus BioSciences, Inc.
- Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer - REDWOOD CITY, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) --...
finacialnews-logo-final-01 (2).png
Technical Innovation Is at Heart of Global Explosion of Smart Glasses Markets as Demand Jumps
December 18, 2024 08:30 ET | FN Media Group LLC
PALM BEACH, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The Global Smart Glasses Market is experiencing significant growth driven by a convergence of technological...
MnM_logo_TM_JPG.JPG
The Rise of Cloud AI Market: A $327.15 billion Industry Dominated by Google (US), IBM (US), AWS (US), Microsoft (US) | MarketsandMarkets™
December 18, 2024 08:30 ET | MarketsandMarkets Research Pvt. Ltd.
Delray Beach, FL, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Cloud AI Market to grow from USD 80.30 billion in 2024 to USD 327.15 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 32.4% during...
logo.jpg
Saratoga Investment Corp. to Report Fiscal Third Quarter 2025 Financial Results and Hold Conference Call
December 18, 2024 08:30 ET | Saratoga Investment Corp
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial results for the fiscal quarter ended November 30, 2024,...
AI Unlimited Group Enters Binding Agreement to Acquire BeyondTrade Securities at $2.95, Enhancing Nest Egg’s Regulated Financial Services Capabilities
December 18, 2024 08:30 ET | AI Unlimited Group, Inc.
LOS ANGELES, Dec. 18, 2024 (GLOBE NEWSWIRE) -- AI Unlimited Group Inc. (OTCQB: AIUG), a leader in AI-powered solutions across fintech, investment, and travel sectors, is pleased to announce a...
Full name logo.png
Remedy Plan Therapeutics Initiates Dosing in Phase 1 Clinical Trial of RPT1G, a First-In-Class Hyperbolic NAMPT Inhibitor
December 18, 2024 08:30 ET | Remedy Plan Therapeutics
Remedy Plan Therapeutics Initiates Dosing in Phase 1 Clinical Trial of RPT1G, a First-In-Class Hyperbolic NAMPT Inhibitor